levofloxacin has been researched along with sulforaphane in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (sulforaphane) | Trials (sulforaphane) | Recent Studies (post-2010) (sulforaphane) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 1,754 | 65 | 1,317 |
| Protein | Taxonomy | levofloxacin (IC50) | sulforaphane (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 9 | |
| Macrophage migration inhibitory factor | Homo sapiens (human) | 2.2 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohanski, MA; Lane, AP; London, NR; Ramanathan, M; Tharakan, A | 1 |
1 other study(ies) available for levofloxacin and sulforaphane
| Article | Year |
|---|---|
Bactericidal antibiotics promote oxidative damage and programmed cell death in sinonasal epithelial cells.
Topics: Anti-Bacterial Agents; Antioxidants; Apoptosis; Caspase 3; Cells, Cultured; DNA Damage; Epithelial Cells; Ethmoid Sinus; Humans; Isothiocyanates; Levofloxacin; Oxidative Stress; Reactive Oxygen Species; Sulfoxides | 2017 |